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ABSTRACT* 
Objectives: The objectives of this study were to determine 
the prevalence of self-medication and to evaluate the 
clinical impact of pharmaceutical counseling.  
Methods: A cross-sectional study was used with a 
prospective component, the latter to evaluate the impact of 
pharmaceutical counseling . The study was conducted in a 
rural community pharmacy for 14 consecutive days in 
December 2012, recruiting all individuals who agreed to 
participate and met the eligibility criteria. During a face-to-
face direct interview demographic and clinical 
characteristics of patients were registered, followed by a 
pharmaceutical intervention, which consisted of evaluating 
the symptoms, selecting the most appropriate non-
prescription medicine (NPM) available and advising the 
patient on pharmacologic and non-pharmacologic 
measures, all according to established protocols for minor 
health problems. When appropriate, the patient was 
referred to a medical appointment. One week later, the 
clinical outcome of such intervention was measured by 
asking the patients about the resolution of their minor 
health problems.  
Results: Data from 298 patients were analyzed, the 
majority being female (60.1%) with an average age of 
44.84 years (SD=22.41). Respiratory problems were the 
most frequent (n=78; 26.2%) and respiratory tract 
medication was the most frequently indicated (n= 77; 
27.8%). The observed prevalence of self-medication was 
40.7%. Of the 271 patients’ beneficiaries of 
pharmaceutical counseling, 86.8% had their minor health 
problems solved after one week (ranging from 77.5% to 
88.2% according to a sensibility analysis for drop-outs). 
Conclusions: This work is important as it demonstrates 
the beneficial impact of pharmaceutical counseling, a very 
relevant area for the pharmacist and where literature is 
particularly scarce. 
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INTRODUCTION 
Pharmaceutical counseling in minor health 
disorders aims at improving and/ or solving minor 
symptoms experienced by patients under self-
medication. The pharmacist has a key role in 
selecting the most appropriate therapy and 
educating the patient for self-care in order to 
achieve positive clinical outcomes, reducing health 
care costs and preventing possible drug-related-
problems.  
There is no agreement on the likely situations that 
can be treated using self-medication in Europe.1 
However, in Portugal, the Medical Doctors Society 
and the Pharmaceutical Society sought an 
agreement and it can be said that there are 
currently 66 situations that can be handled by the 
pharmacist using non-prescription medicines 
(NPMs) which are mentioned in the Legal Dispatch 
no. 17690/2007, published on the 23rd of July.2  
The easy access to the pharmacy, both in terms of 
geographical distribution and in terms of the 
counseling service gratuity, makes it the setting of 
choice for many patients that seek early resolution 
of their minor health problems.3 The pharmacist's 
crucial role is to inform the patient on the correct 
use of the product. It is described that the misuse of 
NPMs is responsible for over 170.000 
hospitalizations per year in the US, corresponding 
to an annual cost of USD750 million. More troubling 
is the reported data that half of these 
hospitalizations could have been prevented through 
more effective education and information directed to 
consumers.4 In Portugal, NPMs may be displayed 
and advertised, but cannot be purchased as a self-
service good since they may only be placed behind 
the counter in a reserved area where only the 
pharmaceutical team can reach.5 
Self-medication may be achieved by using non-
prescription medicines but also by using herbal 
medicines or dietary supplements. The two later 
however do not follow the same above mentioned 
rule as they may be placed in an area of the 
pharmacy directly reached by the public. 
Additionally, the legal dispatch mentioned also does 
not cover for these categories, therefore 
pharmacists do not resort to them as often as they 
do to NPMs.  
There are several studies that characterize the 
current of NPMs in terms of prevalence of self-
medication. Two Portuguese studies have 
researched this topic, presenting estimates of the 
prevalence of self-medication of 26.2% and 21.5%, 
respectively for urban and rural populations.6,7 
Figueiras et al. conducted a study in Spain, 
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indicating a much lower prevalence of self-
medication, reported to be 12.7%.8 More in line with 
Portuguese data, the work by Schmid et al. 
conducted in Brazil found a prevalence of around 
30%.9 Totally unexpected results in this same 
country have been reported by Vosgerau et al., 
suggesting it to go as high as 67.1%.10 All these 
studies are cross-sectional studies. Studies of Melo 
et al and Martins et al evaluated the current use of 
the drug. The study Vosgerau et al. evaluated the 
use of the drug over 7 days and the studies of 
Schmid et al. and Figueiras et al. evaluated the use 
of the drug over 15 days and 14 days respectively. 
There are three necessary stages in the 
pharmaceutical counseling process: stage I clinical 
interview of the patient, stage II pharmaceutical 
intervention and stage III assessing patient’s clinical 
outcomes.1,11-14 As the pharmacist is the main 
source of information for patients when they self-
medicate, his intervention is important so that self-
medication is conducted in a safe, effective and 
rational manner.15 
The literature is scarce in demonstrating the impact 
of pharmaceutical counseling in minor health 
problems on patient´s health. Some studies in this 
context worth mentioning include the work by 
Krishnan and Shaefer, which has shown that 
patients suffering from dyspepsia have reported an 
average increase of 13.6% in their quality of life 
based on the pharmacological and non- 
pharmacological advice given by pharmacists.16 
Sclar et al. have conducted a study in 23 
pharmacies in the Washington state and when 
evaluating the pharmacy services with NPMs 
concluded that pharmaceutical interventions have 
prevented adverse, additional and collateral side 
effects, as well as medical interaction and 
therapeutical duplication in 7.1% of the 745 NPM 
consumers.17 In a study by Bosse et al., the 
reported impact on a 83 patient sample was positive 
in 82.6%, assessed by reported symptom relief.4 
There is not much research that explicitly approach 
the prevalence of pharmaceutical counseling. 
Pharmaceutical counseling may be defined as the 
explicit request from a patient to receive advice from 
a pharmacist. Some studies have used the term 
“symptom-based request”, as opposed to “product-
based request”, the latter being coincident with the 
reports of self-medication, i.e., the patient is the one 
selecting how to treat his minor health problem.18 
The prevalence of pharmaceutical counseling in the 
case study by Martins6 was of 50%, since half of the 
patients requested pharmacist’s counseling. In 
studies by Nunes de Melo7 and Nicole Bosse4 the 
prevalence of pharmaceutical counseling was lower, 
47.2% and 40.1% respectively. The prevalence of 
pharmaceutical counseling depends on the patients’ 
recognition of the pharmacist as a health 
professional able to solve their health issues.19,20  
In the work by Wazaify et al. it is stated that 78% of 
the general public believes that pharmacists play a 
key role in supplying and counseling about the 
safety and effectiveness of NPMs and 63% say that 
they look for pharmaceutical counseling to solve 
minor health problems.19 In the study by You et al 
68% of patients agree to consult the pharmacist 
before using a NPM, thus promoting its correct 
use.20  
This way, it is pointed out that the pharmaceutical 
intervention is part of an educational process of 
patients to self-care when they present themselves 
at the community pharmacy to solve and/ or prevent 
their minor health problems on a self-medication 
basis. It is important to measure the impact of this 
intervention and to estimate the proportion of 
patients that usually resort to this pharmaceutical 
service aiming at its differentiation.  
Literature search undertaken demonstrates that 
there are few studies focusing on the impact of 
pharmaceutical intervention in terms of essential 
services.4,16,17 There is vast literature looking at 
enhanced services, such as medication review or 
pharmaceutical care.21-25 However, the level of 
implementation of essential services is far wider 
than of enhanced services.26,27 Therefore, this study 
aims at filling in the gap by trying to establish the 




Study design and setting  
An intervention study with pre-post analysis was 
conducted between the 3rd and 16th of December 
2012 in one community pharmacy, Farmácia 
Alfeirão, located in Vila Nova de Milfontes, Alentejo, 
Portugal.  
Population and patient sample  
The study population considered was all patients 
who attended this pharmacy during the 
aforementioned time period and met21the inclusion 
criteria.  
Inclusion criteria were defined as presenting at the 
pharmacy with at least one minor symptom or 
directly asking for an NPMs for their personal use. 
Both cases were considered to be self-medication 
as they resulted in the current use of NPMs, 
referred to prevalence of self-medication. 
To estimate the sample size, Epi Info, edition 7 was 
used, considering a total population of 2532 
inhabitants (as defined by law28), prevalence of self-
medication7 of 21.5% and the standard beta and 
alpha errors, indicating 235 patients were needed.  
Patient recruitment  
Patients were individually invited to participate in 
this survey by the working team of Pharmacy 
Alfeirão. All members of the team were duly trained 
for patient recruitment. At this point, patients were 
given information about the study and, after reading 
and signing the informed consent form, they were 
referred to the main pharmacist. One single 
pharmacist conducted all the interviews and 
provided pharmaceutical counseling. The same 
pharmacist was responsible for conducting the 
follow-up interviews after one week, to all patients 
providing contact information for such purpose.  
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Intervention  
All interventions were conducted by the pharmacist 
in charge. The intervention consisted of three 
stages. The first was the clinical interview to the 
patient where biographical data (age and gender) 
were registered, the situation that led the patient to 
seek the pharmacy (asking directly for the drug or 
asking advice from the pharmacist) and the reason 
of the consultation (patient´s minor health problem), 
considering five key questions for assessing the 
situation, known as “WWHAM questions”.29,30 
During the second stage (pharmaceutical 
intervention), the patient´s minor health problem 
were assessed and it was decided, based on 
exclusion criteria for self-medication, to refer or not 
patients for medical appointment.11-13 The patients 
not referred for medical care were targeted for 
pharmaceutical counseling. At this stage, the 
pharmacist selected the most appropriate therapy 
(non-pharmacological measures or pharmacological 
treatment)11,12,14 best suited considering established 
criteria of efficiency, safety, cost and 
convenience11,31 and educated the patient for self-
care.  
Non-pharmacological measures consist of 
treatments that may be used solely or 
supplementary to therapy that will accelerate 
recovery. Some examples are moisture, steam, and 
the rest of the voice in cases of acute hoarseness 
for casual vocal effort or non-pharmacological eyelid 
hygiene and application of moist and warm 
compresses in blepharitis. 
The third stage consisted on the assessment of the 
patient’s clinical outcomes by pharmaceutical or 
medical intervention, after a week, questioning the 
patient about the perception on his/ her symptoms’ 
improvement (whether he/ she got nothing, a little, 
or much better). The patients, who were referred to 
medical consultation, were also asked if they 
already had their appointment or if they were still 
waiting. Should the appointment already have 
happened, the assessment made on symptom 
perception was exactly the same.  
This pharmaceutical intervention was performed 
following the guidance established in Rule 5 of 
Good Pharmacy Practice11, which refers to the 
stages and processes to be followed when 
counseling patients under a self-medication regime 
(Pharmacists Association and National Association 
of Pharmacies).32,33 Further support has been 
obtained from the Protocols of Practice for minor 
disorders developed by the above mentioned 
representative organizations.32,33 Whenever it was 
considered there were gaps in these protocols, a 
reference book for community pharmacy has been 
used "Non-prescription drugs - pharmaceutical 
Counseling”.1 
Data collection  
All study patients were analyzed in terms of socio-
demographic variables, reason for consultation 
mentioned by the patient, assessment of the minor 
condition by the pharmacist, description of the 
pharmaceutical counseling and results of the 
pharmaceutical and medical indication evaluated 
after one week, anticipating the possibility of data 
collection face-to-face or by telephone.  
The Anatomical Therapeutic Chemical classification 
was used, collecting the first level rating code to 
classify indicated medicines.34 
These variables were collected using a service 
record sheet specifically developed for this project 
to assist the pharmacist in the process of 
pharmaceutical counseling. The sheet comprised 
two stages of data collection, seven days apart, 
through individual face-to-face interviews during the 
first week and in person or by telephone during the 
second week of the study.  
The communication method between patient and 
pharmacist was registered. Patients impossible to 
reach after three telephone contact attempts or 
those missing appointment were considered lost to 
follow-up and excluded from the analysis. The 
established protocol for such attempts considered a 
24-hour interval and was always undertaken at the 
time requested by the patient. Minor-aged patients 
received pharmaceutical counseling in the presence 
of an adult caregiver.  
Statistical analysis  
Statistical analysis was undertaken using SPSS 
edition 21.0 (Statistical Package for Social 
Sciences).  
To characterize the studied sample and evaluate 
the proportion of patients that resorted to 
pharmaceutical counseling, descriptive univariate 
analysis was used, comprising central tendency, 
dispersion and shape measures for quantitative 
variables and absolute and relative frequencies for 
qualitative variables.  
Prevalence of self-medication was considered as 
the current use of NPMs and was estimated 
considering all patients who met the inclusion 
criteria as numerator and all patients who during the 
study period entered the pharmacy as the 
denominator. This enabled the estimation of current 
use of NPMs, in the future referred as prevalence of 
self-medication. 
Bivariate analysis was used to assess the impact of 
pharmaceutical counseling, by means of paired 
samples t-tests for continuous variables and chi-
squared tests for categorical variables. The choice 
of parametric statistical tests is justified by sample 
size and the verification of data normality 
distribution assessed by the Kolmogorov-Smirnov 
test.  
Sensitivity analysis was used to account for the 
effects of patients lost to follow-up, where a worst-
case scenario and the opposite were considered. A 
confidence level of 95% was considered for all 
tests.  
Ethics and confidentiality  
All the requirements of ethics and confidentiality of 
the data were completed; hence the researchers 
have resorted to a statement of informed consent 
signed by the participants. Patients’ records with 
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their personal information were coded and kept 
separately to preserve the anonymity and 
confidentiality.  
Since the study is subdivided in a longitudinal and 
cross-sectional component, only patients who 
authorized participation in the longitudinal 
component were requested contact details data. In 
either case, the statement of informed consent was 
conceived in order to be placed on top of the record 
sheet of the pharmaceutical prompt service, being 
detachable so that it was not possible to associate 
the personal data of the patient to the information 
contained in the record sheet.  
The technical director of the pharmacy where the 
study was developed also signed an authorization 
for study development.  
The study has been approved by the Ethics 




The population sample consisted of 731 patients 
who attended the pharmacy during the study period. 
The sample of interest, i.e., patients who were 
carriers of at least a minor disorder meeting the 
inclusion criteria, was 298 patients.  
In this study, the prevalence of self-medication was 
40.7% (298/(731)*100%), these being potential 
candidates for pharmaceutical counseling.  
When analyzing the results, the patient’s request for 
pharmacist advice superseded (n=153, 51.3%) 
patients presenting themselves at the pharmacy 
with a direct-product request (n=145, 48.7%).  
It was mostly women who sought the pharmacy 
(n=179, 60.1%) to solve their minor health problems 
in self-medication scheme.  
The mean age was 44.84 years (SD=22.41) and the 
age group that most resorted to self-medication was 
aged between 26 and 49 years (n=147, 49.3%).  
The most frequent health problems were respiratory 
(26.2%), followed by digestive (20.8%), skin 
(19.1%), muscle or bone (15.4%), and finally 
nervous system problems (13.1%) (Table 1).  
The majority of patients had only one health 
problem on their first visit to the pharmacy (n = 274, 
91.9%), 207 patients (69.5%) had not yet used any 
medicine for that health problem. Among the 
remaining 91 patients who were using or had 
previously used medicines for the presenting health 
problems, 59 did so by their own initiative (61.5% of 
them exclusively singled out this option) and 37 did 
so following a medical prescription (38.5% who 
indicated only this option). It is important to point 
out, there were 5 patients (5.5%) that indicated the 
two options, i.e., they did it for the two 
aforementioned reasons.  
The majority of patients (n=169; 56.7%) were taking 
other medicines at the time. Of these, 81 patients 
(44.8%) reported that it was due to chronic 
condition, 41 (22.6%) because of another 
occasional health problem and 59 (32.6%) reported 
taking them preventively. It should also be 
documented that there were 12 patients (7.1%) who 
reported the two previous answers. A minority of 
patients (n=27; 9.1%) were referred to the doctor, 
and the remaining 271 (90.9%) received 
pharmaceutical counseling for their problem.  
For patients that received pharmaceutical 
counseling, the majority were indicated drug therapy 
(n=147, 49.3%) and only 20 patients received 
exclusively non-pharmacological measures (6.7%). 
Pharmaceutical counseling included both for 131 
patients (44.0%).  
The main therapeutic groups advised in the context 
of pharmaceutical counseling to the 277 patients 
Table 1: Distribution of health problems presented by the patients 






Digestive 62 20.8 20.8 (100.0) 
Respiratory 78 26.2 26.2 (100.0) 
Dermal 57 19.1 19.1 (100.0) 
Nervous system 39 13.1 13.1 (100.0) 
Bone/muscle 46 15.4 15.4 (100.0) 
Fever 6 2.0 2.0 (100.0) 
Asthenia 2 0.7 0.7 (100.0) 
Avitaminosis 8 2.7 2.7 (100.0) 
Ocular 8 2.7 2.7 (100.0) 
Gynecologist 12 4.0 4.0 (100.0) 
Vascular 5 1.7 1.7 (100.0) 
Table 2: Distribution of different therapeutic groups purchased by patients 
Different therapeutic groups purchased by patients Absolute frequency  (n) 
Relative frequency 
 (%) Total 
(A) Digestive tract and metabolism 57 20.6 20.6 (100.0) 
(C) Cardiovascular system 9 3.2 3.2 (100.0) 
(D) Dermal medicines 41 14.8 14.8 (100.0) 
(G) Genito-urinary system and sexual hormones 6 2.2 2.2 (100.0) 
(M) Muscle-skeletal system 74 26.7 26.7 (100.0) 
(N) Nervous system 54 19.5 19.5 (100.0) 
(P) Antiparasitic products, insecticides and insect repellent 9 3.2 3.2 (100.0) 
(R) Respiratory system 77 27.8 27.8 (100.0) 
(S) Sense organs 9 3.2 3.2 (100.0) 
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receiving drug therapy, were medicines for the 
respiratory system (27.8 %), for the muscle-skeletal 
system (26.7%), for the digestive tract and 
metabolism (20.6%), for the nervous system 
(19.5%) and dermatological drugs (14.8%) (Table 
2).  
Of the 298 patients included in the sample, all 
agreed to participate in the second phase of the 
study, giving their contact details. Of these, the 
pharmacist successfully contacted 268 patients 
(89.9%). The remaining 30 patients were lost to 
follow-up.  
The communication method most used between 
pharmacist and patients to assess the outcome of 
pharmaceutical counseling was the telephone 
(n=161, 60.1%), but a still considerably high 
proportion was evaluated face-to-face (n=107; 
39.9%). Yet it is noteworthy that when evaluating 
outcomes face-to-face, there was a statistically 
significant smaller number of patients who reported 
to have improved little or nothing their symptoms 
(25.2% and 8.4% respectively), whereas most of the 
patients that reported to have greatly improved their 
symptoms did so over a telephone assessment 
(p<0.001). 
Therefore, the following results are presented for a 
total of 268 patients. Of the 26 patients successfully 
contacted who had been referred to the doctor, 14 
(53.8%) had already had their medical appointment, 
whilst the remaining 12 (46.2%) were still waiting.  
Of all the patients who participated in the second 
phase of the study, regardless of the 
pharmaceutical intervention performed, 216 patients 
(80.6%) reported that they improved greatly their 
symptoms after one week, while 52 patients 
(19.4%) had improved little or nothing.  
Of the 242 patients that received pharmaceutical 
counseling, 210 (86.8%) reported having greatly 
improved their symptoms, whereas of the 14 
patients who had a medical appointment, 6 (42.9%) 
also reported to have greatly improved their 
symptoms.  
The 32 patients (13.2%) that did not improve or 
slightly improved their symptoms through 
pharmaceutical counseling were referred to medical 
or new pharmaceutical intervention which was not 
recorded due to the end of the study period.  
Hence, one might say that the impact of 
pharmaceutical counseling was positive in 86.8% of 
patients (210/(242)*100%), and was negative in 
13.2% of patients (32/(242)*100%).  
Results from the sensitivity analysis indicate that 
this value may vary from 77.5% of patients 
(210/(271)*100%), assuming that all patients lost to 
follow-up are considered untreated, to 88.2% 
(239/(271)*100%), assuming that all are considered 
treated.  
The study main results are schematically illustrated 
shown in Figure 1 which represents the flowchart of 
patient recruitment.  
Figure 1. Summary flowchart of the main results of the study.
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Patient´s gender was unrelated with the presenting 
intention at the pharmacy (direct product request or 
symptom based request) (p=0.149). In contrast, age 
was associated with the presenting behavior 
(p=0.025), where younger patients more frequently 
requested for pharmaceutical counseling 
(average=42.01, SD=22.564), (Table 3).  
Patients` socio-demographic (gender and age) 
characteristics did not influence the outcome of the 
pharmaceutical counseling (p=0.410, p=0.589 for 
gender and age, respectively) (Table 3). The 
baseline clinical characteristics, i.e., minor health 
problem reported by patients when presenting at the 
pharmacy, did also not influence the resolution of 
the problem (p=0.233) (Table 4). However, data 
indicates that patients with digestive health 
problems (92.7%), nervous system problems 
(90.9%), skin problems (85.4%) and respiratory 
problems (84.2%) improved greatly after 
pharmaceutical counseling.  
The type of pharmaceutical intervention influenced 
the resolution of the patient’s health problem, where 
it was observed that 23.1% of patients referred for a 
medical appointment solved their health problem 
and 86.8% of patients immediately counseled by the 
pharmacist solved their health problem within the 
time frame considered (p<0.001) (Table 4).  
 
DISCUSSION 
The main findings of this study were that during the 
study period, the prevalence of self-medication in 
Vila Nova de Milfontes was 40.7%. Most patients 
presented themselves with a symptom-based 
request (51.3%). Regardless of the presenting 
situation, 90.9% received pharmaceutical 
counseling and only a minority was referred to the 
doctor. After one week of pharmaceutical 
intervention, 86.8% had a positive impact.  
The pharmaceutical counseling proved to be an 
area where investment should be made in different 
fields since about 40% of the patients who attended 
the pharmacy are potential candidates. 
The prevalence of self-medication was significantly 
higher than the values reported by Nunes de Melo7 
and Martins6, which can be due to various factors, 
including those that may be related to reduced 
demand for family physicians, in this case the low 
number of doctors available in Vila Nova de 
Milfontes during the study period, the recent 
increase in moderating fees (a term used to 
regulate access to the Portuguese National Health 
Service) and the different criteria used in the study 
methodology, including the selected definition of a 
self-medication situation. Given that the definition of 
self-medication is not universal, varying according 
to the author, the comparability of data obtained 
from the published literature has become quite 
limited.  
In addition, it is likely that an increased attention 
bias has occurred since the main researcher 
involved in the study was the pharmacist who 
recruited the patient sample, whereas in previous 
studies the recruitment was done by several 
pharmacists. Therefore, it may be expected that 
motivation was higher in the current study.  
Regarding distribution of self-medication by 
demographic characteristics, both gender and age 
distribution, were consistent with previous 
studies.4,6,7,35,36  
The most frequent health problems were similar to 
those reported by Stein35, Csilla Major36, Kerry 
Wilbur37 and consistent with studies elapsed in 
Portugal.17,29 The analyzed literature17-19,28 are 
mostly in accordance with the order of prevalence of 
more frequent health problems, i.e., problems of 
respiratory health and medicines for the respiratory 
system were the most frequent in most studies 
presented.  
Nonetheless, one must consider that seasonality 
influences the prevalence of some of these 
problems, namely the respiratory, which have 
higher expression at this time of the year. Exception 
made to fever, which was reported by a very small 
number of cases (2.0%) considering the time of the 
year when the study was conducted. This fact may 
Table 3: Type of request when presenting at the pharmacy by patients demographic characteristics and outcome of 
problem resolution by patients demographic characteristics. 
 Direct-product request 
Symptom-based  
request p-value HPU HPS p-value 
Gender n (%) n (%)  n (%) n (%)  
Female 81 (45.3) 98 (54.7) 0.149a 18 (11.8) 134 (88.2) 0.410a Male 64 (53.8) 55 (46.2) 14 (15.6) 76 (84.4) 
 μ (SD) μ (SD)  μ (SD) μ (SD)  
Age 47.82 (21.93) 42.01 (22.56) 0.025b 45.93 (23.88) 43.64 (22.07) 0.589b 
Notes: μ – average; SD – standard deviation; aChi-square test; bStudent t Test. HPU=Health Problem Unsolved, 
HPS=Health Problem Solved. 
Table 4: Variable descriptive study: health problems and type of pharmaceutical intervention. 
Variable HPU* n (%) 
HPS* 
n (%) Value p 
Presenting Health problem** 
Respiratory 9 (15.8) 48 (84.2) 
0.233c 
Digestive 3 (7.3) 38 (92.7) 
Dermal  7 (14.6) 41 (85.4) 
Muscle or bone 7 (28.0) 18 (72.0) 
Nervous system 2 (9.1) 20 (90.9) 
Type of pharmaceutical intervention Medical referral 20 (76.9) 6 (23.1) <0.001a Pharmaceutical indication 32 (13.2) 210 (86.8) 
Notes: aChi-square test; c Fisher’s test; *HPU=Health Problem Unsolved; HPS=Health Problem Solved; **Narrowing the 
analysis to just the 5 more frequent clinical categories. 
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be explained by the definition adopted for the 
present study, which considered fever only in the 
cases where patients had confirmed their body 
temperature. This methodological option may 
possibly be considered open for discussion since 
the self-diagnosis of the other minor symptoms did 
not require any confirmation, namely observation of 
the throat or ears.  
Perhaps the most interesting and motivating result 
of the current study is the high proportion of patients 
(86.8%) that perceived the pharmaceutical 
intervention to have a positive impact on their 
health-related problems. In a study by Nicole Bosse, 
similar results have been presented with 82.6% of 
an 83-patient sample reporting great relief following 
one week of pharmaceutical intervention.4  
This study is valuable for various reasons. Firstly, 
the sample obtained superseded the sample size 
estimated and additionally socio-demographic 
characteristics of the sample were very similarly 
distributed to the reference population (Table 5), 
indicating the sample was representative.28 
Secondly, it focuses on a little researched area, 
albeit very common in daily practice. Community 
pharmacists put great effort on providing excellent 
care to their patients, but researchers seem to fail 
demonstrating its value. As such, there have been 
countries that for decades now have demonstrated 
the value of various pharmaceutical services and 
have even gained recognition of their importance by 
achieving remuneration, such as the case of 
Switzerland, The Netherlands and Denmark, to 
name a few.27 Portugal has not yet been able to do 
so. This project will certainly provide a modest 
contribution for the recognition of an important 
pharmaceutical service with demonstrated positive 
health outcome.  
Nonetheless, it must be acknowledged that the 
study also has important limitations. Firstly, the 
study design chosen is not the ideal to demonstrate 
with high degree of evidence the value of the 
pharmaceutical intervention, as a RCT or a 
community trial would be a better approach. Indeed, 
given the fact that the health problems are self-
limiting conditions, a control group would be needed 
to provide indisputable evidence that the 
improvement in patients’ health status can be 
attributed to the pharmaceutical intervention. 
Additionally, internal factors, such as medication 
adherence, and other external factors, such as 
resorting to complementary medicine, may have 
contributed to clinical improvement, that without 
such designs one could not control for. However, 
conducting a RCT would have ethical implications 
that would invalidate its carrying out in a single 
pharmacy with a single pharmacist and the 
community trial approach would imply involving 
more pharmacies, which was not feasible given the 
timeline of the study (MSc project).  
Additionally, it should be noted that if one wished to 
compare the effectiveness of the pharmaceutical 
intervention with the medical one, the time period 
would have had to be extended beyond 7 days. If 
such was the case, one would also need a larger 
number of medical referrals, as these were clearly 
few in the current study.  
It was not the intention of this study to assess the 
sustainability of the pharmaceutical counseling in 
clinical terms. Nevertheless, it would be interesting 
to do it and in doing so the period of patients’ follow-
up had equally to be extended.  
The short time period of the study also failed to 
evaluate patients that were waiting for a medical 
appointment and the outcome of therapy prescribed 
to 8 patients (57.1%) which began their treatments 
very near of the 7th day of the pharmaceutical 
review.  
It must be recognized that some of the outcomes 
intended to measure are not achievable after one 
week. An example is the case of acquisition of 
vitamins for the prevention of vitamin deficiencies 
(avitaminosis), it is impossible for the patient to 
have any perception of the drug´s efficacy (or lack 
of it) after one week and therefore may not report 
the problem to have been solved. This may have 
negatively influenced the presented results. 
However, this aspect is negligible since only 8 
patients (2.7%) reported this health problem. Still, 
one must consider that this pharmacotherapeutic 
class should be excluded in future studies 
examining the outcomes of pharmaceutical 
intervention.  
Another limitation of the study was that the 
questionnaire was not tested and it became 
inconsistent in the assessment criteria of multiple 
health problems, i.e., when the patient reported 
more than one presenting condition, the outcome 
was assessed in a holistic manner. Still, this fact is 
not relevant since only 8 % of the sample reported 
having more than one health problem. However, 
one did not evaluate if during the course of the 
study additional health problems have arisen.  
An important limitation is that existing protocols do 
not cover all spectra of pharmaceutical counseling 
and not all of those existing are validated. Hence 
the therapeutic options made may be criticized as 
they are not universally recognized, which limits the 
comparison to studies by other authors.  
Finally, it is important to reflect on the potential 
biases in interpreting the study’s main result, which 
indicates an extremely high impact of 
pharmaceutical counseling. It is widely reported that 
there is a tendency for patients to attempt to 
Table 5: Comparison of socio-demographic characteristics 
of the sample with the reference population n (%) 
Characteristic Sample Reference population* 
Gender   
Female 179 (60.1) 2551 (50.70) 
Male 119 (39.9) 2480 (49.30) 
Age group   
15 – 24 42 (14.10) 478 (11.38) 
25 – 64 185 (62.10) 2789 (66.39) 
65 or more 71 (23.80) 934 (22.23) 
*Notes: Censos 2011 – Resultados Definitivos Alentejo, 
Instituto Nacional de Estatística. Portugal. Available at: 
http://www.ine.pt. The age group <15 years was not 
considered because it was na exclusion criteria of the 
study. Therefore data presented assumes that 100% of 
the reference population is over 15 years of age. 
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transmit a socially acceptable image, avoiding 
critical situations test (social desirability bias). This 
phenomenon may be exacerbated if the evaluator is 
also their usual pharmacist, possibly leading them 
to more likely report on improving minor symptoms 
in an effort to please their caregiver, which was the 
case. 
Additionally, it should be stated that the fact that 
there were significant differences on the level of 
improvement reported when comparing face-to-face 
and telephone assessment is cause of concern and 
may have two explanations. Patients assessed over 
the phone were those that did not return to the 
pharmacy, and therefore may be expected to be 
those perceiving greater improvement. On the other 
hand, if one assumes there was social desirability 
bias, then one could expect that this were more 
evident face-to-face, which was not the case. Either 
way, in future studies, for purposes of internal 
validity the method of assessment should be the 
same for all patients. 
Another aspect briefly mentioned but worth 
highlighting, is that the conditions studied are self-
limiting, so in fact one cannot ensure that health 
improvement was a direct result of the 
pharmaceutical counseling.38 However, one cannot 
also rule out the possibility that the pharmaceutical 
counseling led to quicker recovery, an issue worth 
exploring in future studies involving a control group.  
For all the above mentioned reasons, one cannot 
state there is certainly a causal relationship 
between pharmaceutical counseling and patients’ 
outcomes. However, this establishes strong 
hypothesis on such relationship that need further 
evidence by stronger study designs.  
The process of pharmaceutical counseling should 
ideally take place in a private office; however, this 
would not reflect daily practice and for such reason 
counseling in this study was done mainly at the 
counter. The downside to such approach is that it 
may have restricted the depth of the initial 
assessment and non-pharmacological advice 
provided.  
Nonetheless, the presented data indicates that 
pharmaceutical counseling led to consistent results 
for all patients regardless of their gender and age 
and of the type of presented minor health problem. 
The main difference found in outcomes was that the 
type of pharmaceutical intervention influenced the 
resolution of the patient’s health problem, i.e., 
patients referred for medical appointment reported a 
lower proportion of positive outcomes. One 
explanation for this was due to the shortage of 
doctors, the waiting time for medical appointment 
and the short study period to continue to obtain 
more clinical results. Further studies to evaluate the 
effectiveness of evidence-based NPMs would also 
be needed, its long-term impact and cost-
effectiveness of this type of pharmaceutical 
intervention.39 As well as studies assessing the 
behavior of the community pharmacist in their daily 
practice, with the aim of being able to implement 
training to improve their counseling to the 
patient.40,41 
Despite all limitations mentioned, it should be 
acknowledged that the research aims were met and 
it could be demonstrated that the pharmaceutical 
intervention in this study contributed to the 
prevention and treatment of most minor health 
problems of patients attending community 
pharmacy under a self-medication situation. 
 
CONCLUSIONS 
This study demonstrates that the proportion of 
individuals who resorted to self-medication in Vila 
Nova de Milfontes was 40.7%. Thus it can be said 
that almost half of the patients of a pharmacy are 
potential candidates for pharmaceutical counseling. 
The results showed that 86.8% of patients improved 
their minor health symptoms. This means that the 
pharmaceutical intervention, consisting of the 
selection of the most appropriate therapy and the 
provision of information, resulted in better self-care 
for a vast majority of patients. 
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IMPACTO DEL CONSEJO FARMACÉUTICO EN 




Objetivos: Los objetivos de este estudio fueron 
determinar la prevalencia de auto-medicación y evaluar 
el impacto clínico del consejo farmacéutico. 
Métodos: Se utilizó un estudio transversal con un 
componente predictivo para evaluar el impacto del 
consejo farmacéutico. El estudio se realizó en una 
farmacia comunitaria rural durante 14 días consecutivos 
en diciembre de 20012, reclutando a todos los individuos 
que aceptaron participar y cumplían los criterios de 
elegibilidad. Durante una entrevista presencial directa se 
registró los datos demográficos y clínicos, seguido de una 
intervención farmacéutica que consistía en evaluar los 
síntomas, seleccionar el medicamento sin receta (NPM) 
disponible más adecuado, y aconsejar al paciente sobre 
medidas farmacológicas y no farmacológicas, de acuerdo 
a protocolos establecidos para síntomas menores. Cuando 
era adecuado, se refería al paciente al médico. Una 
semana más tarde, se medía el resultado clínico de la 
intervención preguntando a los pacientes por la 
resolución de sus problemas de salud menores. 
Resultados: Se analizaron datos de 298 pacientes, la 
mayoría eran mujeres (60,1%) con una edad media de 
44,84 años (DE=22,41). Los problemas respiratorio serán 
los más frecuentes (n=78; 26.2%), y los medicamentos 
del tracto respiratorio la medicación más frecuentemente 
indicada (n= 77; 27.8%). La prevalencia observada de 
auto-medicación fue del 40,7%. De los 271 pacientes 
beneficiarios del consejo farmacéutico, el 86,8% tenía 
problemas de salud menores que se resolvieron tras una 
semana (oscilando del 77,5% al 88,2% de acuerdo a un 
análisis de sensibilidad para las pérdidas). 
Conclusiones: Este trabajo es importante ya que 
demuestra el impacto beneficioso del consejo 
farmacéutico, un área muy importante y en la que la 
literatura farmacéutica es particularmente escasa. 
 
Palabras clave: Medicamentos sin Prescripción; 
Consejo; Servicios de Farmacia Comunitaria; Práctica 
Profesional; Farmacéuticos; Portugal 
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